Development and validation of the Glaucoma Risk Stratification Questionnaire for community screening

Purpose Glaucoma is a leading cause of irreversible blindness, and community detection is hampered by the lack of accessible, low-cost screening tools. We developed and validated the Glaucoma Risk Stratification Questionnaire (GRSQ), a questionnaire-based instrument for identifying individuals at risk of glaucoma in Chinese communities. Methods This hospital-based cross-sectional study, constituting the instrument development and validation phase of a community screening program, was conducted at West China Hospital, Sichuan University, from December 2025 to August 2026. In total, 413 participants were enrolled: 207 with confirmed glaucoma (Group A), 100 glaucoma suspects (Group B) and 106 normal controls (Group C). The item pool was refined by a two-round Delphi process with 13 glaucoma experts, and psychometric properties were evaluated by item analysis, exploratory and confirmatory factor analysis (EFA, CFA), internal consistency, one-way ANOVA and ROC curve analysis. Results The Delphi process retained 24 items, from which a 14-item, three-factor structure was established after item analysis and EFA (46.7% of variance): ocular symptoms (6 items), psychological factor and corticosteroid use (3 items) and systemic disorders (3 items), with two items scored independently. CFA in an independent sample ( n = 206) showed acceptable fit (CFI = 0.921, TLI = 0.898, RMSEA = 0.060), and the total-scale Cronbach’s alpha was 0.719. GRSQ scores differed significantly among the three groups ( F (2,410) = 96.23, p < 0.001): 9.86 ± 3.97, 6.69 ± 4.35 and 3.55 ± 3.08 in Groups A, B and C. The area under the ROC curve (AUC) was 0.816 (95% CI, 0.773–0.857; p < 0.001), with 82.1% sensitivity and 72.3% specificity at the optimal cutoff of 6.5. A three-tier risk stratification system was established: low (0–5), moderate (6–9) and high risk (≥ 10). Conclusion GRSQ demonstrated acceptable structural validity, acceptable reliability at the total-scale level and good discriminative ability, representing a practical and accessible tool for identifying individuals at risk of glaucoma who may benefit from comprehensive ophthalmic examinations in resource-limited community settings.

Authors

Institutions

Publication Details

Journal
Frontiers in Public Health
Published
2026-11-11
DOI
https://doi.org/10.3389/fpubh.2026.1963928
Primary Topic
Glaucoma and retinal disorders
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Development and validation of the Glaucoma Risk Stratification Questionnaire for community screening

Jiang Shanming, Haotian Xiang, Xianjie Yu, Vincentius Yonathan Evandrew et al.
Frontiers in Public Health
Glaucoma and retinal disorders
article

Development and validation of the Glaucoma Risk Stratification Questionnaire for community screening

Jiang Shanming, Haotian Xiang, Xianjie Yu, Vincentius Yonathan Evandrew, Li Tang, Xiangyu Fu, Jiaying Zhang, Yutong Liu, Caizhi Wu, Meng Wang
article en

Abstract

Purpose Glaucoma is a leading cause of irreversible blindness, and community detection is hampered by the lack of accessible, low-cost screening tools. We developed and validated the Glaucoma Risk Stratification Questionnaire (GRSQ), a questionnaire-based instrument for identifying individuals at risk of glaucoma in Chinese communities. Methods This hospital-based cross-sectional study, constituting the instrument development and validation phase of a community screening program, was conducted at West China Hospital, Sichuan University, from December 2025 to August 2026. In total, 413 participants were enrolled: 207 with confirmed glaucoma (Group A), 100 glaucoma suspects (Group B) and 106 normal controls (Group C). The item pool was refined by a two-round Delphi process with 13 glaucoma experts, and psychometric properties were evaluated by item analysis, exploratory and confirmatory factor analysis (EFA, CFA), internal consistency, one-way ANOVA and ROC curve analysis. Results The Delphi process retained 24 items, from which a 14-item, three-factor structure was established after item analysis and EFA (46.7% of variance): ocular symptoms (6 items), psychological factor and corticosteroid use (3 items) and systemic disorders (3 items), with two items scored independently. CFA in an independent sample ( n = 206) showed acceptable fit (CFI = 0.921, TLI = 0.898, RMSEA = 0.060), and the total-scale Cronbach’s alpha was 0.719. GRSQ scores differed significantly among the three groups ( F (2,410) = 96.23, p < 0.001): 9.86 ± 3.97, 6.69 ± 4.35 and 3.55 ± 3.08 in Groups A, B and C. The area under the ROC curve (AUC) was 0.816 (95% CI, 0.773–0.857; p < 0.001), with 82.1% sensitivity and 72.3% specificity at the optimal cutoff of 6.5. A three-tier risk stratification system was established: low (0–5), moderate (6–9) and high risk (≥ 10). Conclusion GRSQ demonstrated acceptable structural validity, acceptable reliability at the total-scale level and good discriminative ability, representing a practical and accessible tool for identifying individuals at risk of glaucoma who may benefit from comprehensive ophthalmic examinations in resource-limited community settings.

Frontiers in Public HealthVol. 14
Sichuan University (CN), West China Hospital of Sichuan University (CN)
Glaucoma and retinal disorders
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon